Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.25USD
16 Feb 2018
Change (% chg)

$0.15 (+7.14%)
Prev Close
$2.10
Open
$2.10
Day's High
$2.29
Day's Low
$2.10
Volume
45,263
Avg. Vol
60,448
52-wk High
$10.86
52-wk Low
$1.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 5.60 6.20 5.00 5.28
Quarter Ending Jun-18 2 5.60 6.20 5.00 20.28
Year Ending Dec-18 6 24.48 37.70 18.00 45.94
Earnings (per share)
Quarter Ending Mar-18 2 -0.34 -0.27 -0.41 -0.95
Quarter Ending Jun-18 2 -0.34 -0.29 -0.40 -0.63
Year Ending Dec-18 6 -1.36 -1.10 -1.69 -2.49
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta 2.20 0.82 0.81
Price to Sales (TTM) 3.59 140.57 8.57
Price to Book (MRQ) -- 18.76 5.14
Price to Tangible Book (MRQ) -- 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 70.15 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -13.74 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -7.92 45.64 7.30
Sales - 5 Yr. Growth Rate -4.35 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 62.95 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago 42.05 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -12.42 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 3.39 6.17 3.38
LT Debt to Equity (MRQ) -- 16.64 11.85
Total Debt to Equity (MRQ) -- 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -283.90 -- --
EBITD - 5 Yr. Avg -181.75 -567.40 9.86
Operating Margin (TTM) -301.74 -697.09 1.25
Operating Margin - 5 Yr. Avg. -186.73 -588.12 5.07
Pre-Tax Margin (TTM) -298.55 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -186.42 -596.31 5.33
Net Profit Margin (TTM) -298.60 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -187.38 -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,525 23,305,201 819,569,446
Net Income/Employee (TTM) -580,844 -626,600 95,804,981
Receivable Turnover (TTM) 18.28 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.14 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.85 -1.27 10.68
Return on Assets - 5 Yr. Avg. -27.30 -0.48 12.00
Return on Investment (TTM) -56.95 -1.15 13.54
Return on Investment - 5 Yr. Avg. -34.15 2.13 15.72
Return on Equity (TTM) -- -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -21.60 -19.36 10 71
13 Week -56.81 -59.24 3 93
26 Week -47.06 -53.00 7 86
52 Week -74.05 -77.71 5 87
YTD -45.12 -46.30 3 90
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.15%
# of Holders: 91
Total Shares Held: 26,556,246
3 Mo. Net Change: -1,111,437
# New Positions: 18
# Closed Positions: 9
# Increased Positions: 38
# Reduced Positions: 35
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.